CHICAGO (Reuters) - An early stage study suggests an experimental vaccine may be able to tame bits of the immune system that go haywire in people with type 1 diabetes, offering hope for a new way to delay or prevent the autoimmune disease, researchers said on Wednesday. Full story
PARIS (Reuters) - An improved version of Sanofi's blockbuster insulin Lantus is better than the older drug at controlling blood sugar lows at night, a common side effect in diabetics treated with insulin, according two late-stage tests published on Saturday. Full story
CHICAGO (Reuters) - Type 1 diabetics, who run the risk of dangerously low blood sugar, may be a step closer to getting help from a crude artificial pancreas device that can read blood sugar levels and automatically turn off the flow of insulin after a clinical trial showed the device is safe. Full story
FRANKFURT (Reuters) - In a leafy suburb of Frankfurt, a state-of-the-art plant churns out up to 1 million insulin pens every day in French drugmaker Sanofi's drive to keep its no. 2 spot in the $43 billion-a-year diabetes market. Full story
A new study published in The American Journal of Medicine finds marijuana smokers have better insulin control and smaller waists. MSNBC’s Lawrence O’Donnell discusses the study with Dr. Murray Mittleman of the Harvard School of Public Health, one of the co-authors of the study.
In Mika Brzezinski's latest book "Obsessed," Sen. Claire McCaskill, D-Mo., tells her story of a life-changing moment where she knew she needed to improve her physical health. Sen. McCaskill joins Morning Joe to discuss her weight-loss journey.
A new study says Hispanics are more likely to store fat in their pancreas, but less likely to be able to produce more insulin to compensate for this excess fat, putting them at higher risk for type 2 diabetes. KVEO's Michael Lopez reports.
Naomi Wyatt of the Camden Coalition of Health Care Providers joins The Dylan Ratigan Show to talk about hot-spotting in health care.
A promising study funded by the National Institutes of Health found that a spritz of insulin may improve memory in Alzheimer’s patients. NBC’s Robert Bazell has more.
A diabetic patient displays her insulin supplies and blood sugar level-testing device at the J.W.C.H. safety-net clinic in the center of skid row in downtown Los Angeles, July 30, 2007. REUTERS/Lucy Nicholson
An employee works on a Novo Nordisk production line for the new long-acting insulin Tresiba drug, in this August 18, 2012 handout picture provided by Novo Nordisk. U.S. regulators on February 10, 2013 dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the
The new long-acting insulin Tresiba drug is seen on a Novo Nordisk production line, in this 2012 handout picture provided by Novo Nordisk. U.S. regulators on February 10, 2013 dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct